Published in Atten Defic Hyperact Disord on November 30, 2010
Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study. J Child Adolesc Psychopharmacol (2012) 0.95
Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges. Atten Defic Hyperact Disord (2013) 0.82
Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents? Child Adolesc Psychiatry Ment Health (2011) 0.78
Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries. Eur J Clin Pharmacol (2016) 0.77
Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine. Patient Prefer Adherence (2016) 0.75
Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects. Arch Dis Child (2016) 0.75
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med (2006) 5.56
Trends in the prescribing of psychotropic medications to preschoolers. JAMA (2000) 5.02
Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry (1993) 4.71
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2002) 4.57
Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA (2001) 2.53
Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry (2000) 2.10
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 2.01
A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health (2008) 1.95
The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med (2005) 1.83
The global market for ADHD medications. Health Aff (Millwood) (2007) 1.83
National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin Pediatr (Phila) (1999) 1.77
Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics (1996) 1.76
Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics (1993) 1.75
Trends in medication treatment for ADHD. J Atten Disord (2007) 1.74
The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. J Consult Clin Psychol (1990) 1.63
Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr (2006) 1.63
[Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003]. Ned Tijdschr Geneeskd (2005) 1.59
The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. J Child Psychol Psychiatry (1991) 1.54
Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. Arch Pediatr Adolesc Med (2003) 1.52
Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther (2008) 1.42
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother (2007) 1.42
Injuries to children with attention deficit hyperactivity disorder. Pediatrics (1998) 1.41
Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health (2008) 1.37
Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am (2004) 1.27
Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (2005) 1.26
Multiple psychotropic medication use for youths: a two-state comparison. J Child Adolesc Psychopharmacol (2005) 1.26
Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol (2004) 1.22
Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child Adolesc Psychopharmacol (2007) 1.22
Prescription of methylphenidate to children and youth, 1990-1996. CMAJ (2001) 1.21
Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2005) 1.20
Psychotropic medication in children: a study from the Netherlands. Pediatrics (2001) 1.18
Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed. Aust N Z J Public Health (2007) 1.07
Prevalence of methylphenidate use among Israeli children: 1998-2004. Clin Drug Investig (2006) 1.06
National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry (2008) 1.05
Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry (2007) 1.05
The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics (1994) 1.03
An international perspective on pediatric psychopharmacology. Int Rev Psychiatry (2008) 0.95
Use of psychostimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry (2002) 0.93
Second opinions improve ADHD prescribing in a medicaid-insured community population. J Am Acad Child Adolesc Psychiatry (2009) 0.93
Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci (2005) 0.93
Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. J Child Adolesc Psychopharmacol (2010) 0.93
Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006. Br J Clin Pharmacol (2009) 0.92
A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). BMC Health Serv Res (2009) 0.88
Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment. J Child Adolesc Psychopharmacol (2004) 0.85
Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD). J Neural Transm (Vienna) (2008) 0.84
Datapoints: trends in ADHD and stimulant use among adults: 1995-2002. Psychiatr Serv (2005) 0.81
Changes in use of psychostimulant medication for ADHD in South Australia (1990-2006). Aust N Z J Psychiatry (2009) 0.81
Psychotropic co-medication among stimulant-treated children in The Netherlands. J Child Adolesc Psychopharmacol (2005) 0.80
Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces. Can J Psychiatry (2008) 0.79
Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm (2007) 0.77
[The prevalence of ADHD in the Belgian general adult population: an epidemiological explanatory study]. Tijdschr Psychiatr (2008) 0.76
Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc (2005) 4.01
The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry (2006) 3.86
Theory of mind in schizophrenia: meta-analysis. Br J Psychiatry (2007) 2.87
Minicolumnar abnormalities in autism. Acta Neuropathol (2006) 2.62
Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study. Addiction (2013) 2.46
A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: deficient inhibitory motor control? J Abnorm Psychol (2005) 2.39
Frequency and determinants of drug administration errors in the intensive care unit. Crit Care Med (2002) 2.35
Neuropathological findings in autism. Brain (2004) 2.34
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med (2007) 2.09
Klinefelter's syndrome (karyotype 47,XXY) and schizophrenia-spectrum pathology. Br J Psychiatry (2006) 1.97
Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf (2010) 1.91
Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. Eur J Pediatr (2007) 1.84
Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med (2004) 1.76
Screening for autistic spectrum disorder in children aged 14-15 months. II: population screening with the Early Screening of Autistic Traits Questionnaire (ESAT). Design and general findings. J Autism Dev Disord (2006) 1.74
Changes in the developmental trajectories of striatum in autism. Biol Psychiatry (2009) 1.71
Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry (2005) 1.71
Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry (2007) 1.70
Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68
Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics (2009) 1.66
Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J (2013) 1.58
Screening for autistic spectrum in children aged 14 to 15 months. I: the development of the Early Screening of Autistic Traits Questionnaire (ESAT). J Autism Dev Disord (2006) 1.58
Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens (2005) 1.58
Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest (2013) 1.55
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids (2009) 1.54
Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry (2004) 1.53
Attentional effects of gaze shifts are influenced by emotion and spatial frequency, but not in autism. J Am Acad Child Adolesc Psychiatry (2008) 1.52
Neurons in the fusiform gyrus are fewer and smaller in autism. Brain (2008) 1.50
Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail (2003) 1.50
The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME). Transfusion (2012) 1.50
Effect of oral antiplatelet agents on major bleeding in users of coumarins. Thromb Haemost (2008) 1.48
Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother (2005) 1.47
Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc (2008) 1.46
Association between statin use and lupus-like syndrome using spontaneous reports. Semin Arthritis Rheum (2011) 1.43
Initiation of antidepressant therapy: do patients follow the GP's prescription? Br J Gen Pract (2009) 1.42
Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. Ann Pharmacother (2009) 1.40
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol (2008) 1.40
Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder. Biol Psychiatry (2006) 1.39
Social behavior and autism traits in a sex chromosomal disorder: Klinefelter (47XXY) syndrome. J Autism Dev Disord (2008) 1.39
Parental sensitivity and attachment in children with autism spectrum disorder: comparison with children with mental retardation, with language delays, and with typical development. Child Dev (2007) 1.34
No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol (2007) 1.33
High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum (2011) 1.30
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med (2008) 1.30
Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases. Drug Saf (2013) 1.29
Familial vulnerability to ADHD affects activity in the cerebellum in addition to the prefrontal systems. J Am Acad Child Adolesc Psychiatry (2008) 1.27
Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord (2006) 1.26
Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging (2009) 1.26
Executive functions in preschool children with aggressive behavior: impairments in inhibitory control. J Abnorm Child Psychol (2008) 1.25
Audiovisual speech integration in pervasive developmental disorder: evidence from event-related potentials. J Child Psychol Psychiatry (2008) 1.25
Reactive and proactive aggression in children--a review of theory, findings and the relevance for child and adolescent psychiatry. Eur Child Adolesc Psychiatry (2005) 1.24
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother (2005) 1.23
The neurobiology of repetitive behavior: …and men. Neurosci Biobehav Rev (2010) 1.23
Gene-network analysis identifies susceptibility genes related to glycobiology in autism. PLoS One (2009) 1.23
Differentiation between autism and multiple complex developmental disorder in response to psychosocial stress. Neuropsychopharmacology (2002) 1.23
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care (2006) 1.22
Stress responsivity in children with externalizing behavior disorders. Dev Psychopathol (2004) 1.22
Stroop interference and attention-deficit/hyperactivity disorder: a review and meta-analysis. Neuropsychology (2007) 1.21
Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. Biol Psychiatry (2006) 1.21
Intranasal oxytocin increases fathers' observed responsiveness during play with their children: a double-blind within-subject experiment. Psychoneuroendocrinology (2010) 1.20
Renal function assessment in older adults. Br J Clin Pharmacol (2013) 1.19
Basic impairments in regulating the speed-accuracy tradeoff predict symptoms of attention-deficit/hyperactivity disorder. Biol Psychiatry (2010) 1.19
Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. BMC Health Serv Res (2007) 1.16
Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res (2007) 1.16
Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia (2006) 1.12
Psychiatric morbidity and X-chromosomal origin in a Klinefelter sample. Schizophr Res (2007) 1.10
Cortisol and treatment effect in children with disruptive behavior disorders: a preliminary study. J Am Acad Child Adolesc Psychiatry (2004) 1.10
Brief report: can you see what is not there? low-level auditory-visual integration in autism spectrum disorder. J Autism Dev Disord (2007) 1.10
Neural and behavioral correlates of expectancy violations in attention-deficit hyperactivity disorder. J Child Psychol Psychiatry (2007) 1.10
Inter-rater reliability and stability of diagnoses of autism spectrum disorder in children identified through screening at a very young age. Eur Child Adolesc Psychiatry (2009) 1.09
Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. Pharmacogenomics (2007) 1.09
Brief report: eye movements during visual search tasks indicate enhanced stimulus discriminability in subjects with PDD. J Autism Dev Disord (2007) 1.09
The neurobiology of repetitive behavior: of mice…. Neurosci Biobehav Rev (2010) 1.09
X Chromosomal effects on social cognitive processing and emotion regulation: A study with Klinefelter men (47,XXY). Schizophr Res (2006) 1.08
Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community. Eur Heart J (2013) 1.08
Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes. PLoS One (2010) 1.08
Executive functioning in children: a comparison of hospitalised ODD and ODD/ADHD children and normal controls. J Child Psychol Psychiatry (2004) 1.08
Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res (2010) 1.07
Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med (2002) 1.07
A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 1.06
Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. Ageing Res Rev (2012) 1.06
Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials. Eur J Clin Pharmacol (2008) 1.05
Variability in spatial normalization of pediatric and adult brain images. Clin Neurophysiol (2005) 1.05
Reimbursement restriction and moderate decrease in benzodiazepine use in general practice. Ann Fam Med (2012) 1.04
The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners. Ann Pharmacother (2007) 1.03
Attachment in toddlers with autism and other developmental disorders. J Autism Dev Disord (2007) 1.03
Salivary testosterone and aggression, delinquency, and social dominance in a population-based longitudinal study of adolescent males. Horm Behav (2006) 1.03
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol (2005) 1.03
The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens (2004) 1.03
Overlap of autistic and schizotypal traits in adolescents with Autism Spectrum Disorders. Schizophr Res (2010) 1.03
Superior disembedding performance of high-functioning individuals with autism spectrum disorders and their parents: the need for subtle measures. J Autism Dev Disord (2006) 1.03
Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet (2009) 1.02
A neural substrate for atypical low-level visual processing in autism spectrum disorder. Brain (2008) 1.02
Progressive structural brain changes during development of psychosis. Schizophr Bull (2010) 1.01
Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology (2008) 1.01
Inhibition in children with attention-deficit/hyperactivity disorder: a psychophysiological study of the stop task. Biol Psychiatry (2002) 1.00